{"transactions":[{"id":1996365,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":116545,"kind":"person","name":"Davis Jeremy Steven","position":1,"cik":"0001919871","reported_name":"Davis Jeremy Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-24T02:45:13.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":20833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023."}],"balance_after":229167,"derivative":{"underlying":"Common Stock","underlying_shares":20833},"source":{"system":"sec-edgar","filing":"0001162194-23-000010","document":"wf-form4_167720668432890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000010/wf-form4_167720668432890.xml","form_type":"4"}},{"id":1996364,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":116545,"kind":"person","name":"Davis Jeremy Steven","position":1,"cik":"0001919871","reported_name":"Davis Jeremy Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-24T02:45:13.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":6176,"price":2.03,"value":12537.28,"ownership":{"direct":true},"balance_after":14657,"source":{"system":"sec-edgar","filing":"0001162194-23-000010","document":"wf-form4_167720668432890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000010/wf-form4_167720668432890.xml","form_type":"4"}},{"id":1996363,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":116545,"kind":"person","name":"Davis Jeremy Steven","position":1,"cik":"0001919871","reported_name":"Davis Jeremy Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-24T02:45:13.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":20833,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20833,"source":{"system":"sec-edgar","filing":"0001162194-23-000010","document":"wf-form4_167720668432890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000010/wf-form4_167720668432890.xml","form_type":"4"}},{"id":2049911,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":116545,"kind":"person","name":"Davis Jeremy Steven","position":1,"cik":"0001919871","reported_name":"Davis Jeremy Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-20T22:24:45.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of LAB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in quarterly installments over the course of four years commencing February 20, 2023."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001162194-23-000002","document":"wf-form4_167425346769614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000002/wf-form4_167425346769614.xml","form_type":"4"}},{"id":2292918,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":116545,"kind":"person","name":"Davis Jeremy Steven","position":1,"cik":"0001919871","reported_name":"Davis Jeremy Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-21T22:21:02.000Z","date":"2022-04-20","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter."}],"balance_after":250000,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001162194-22-000047","document":"wf-form4_165057963638945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000047/wf-form4_165057963638945.xml","form_type":"4"}}]}